ArticleInternational journal of molecular medicine2019

Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of Nrf2 expression.

Haipeng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.